aLiFE n=59 | eLiFE n=61 | |
Age (years), mean (SD) | 66.19 (2.32) | 66.43 (2.33) |
Gender (female), n (%) | 30 (50.8) | 33 (54.1) |
Living alone, n (%) | 21 (36.7) | 18 (29.5) |
Pain during rest (0–10), median (IQR) | 1.0 (1.0–3.0) | 1.0 (1.0–3.0) |
Pain during walking (0–10), mean (SD) | 2.5 (1.0–4.0) | 2.0 (1.0–4.5) |
Falls in past year, n (%) | ||
0 | 53 (91.4) | 51 (83.6) |
1 | 4 (6.9) | 10 (16.4) |
2+ | 1 (1.7) | 0 (0) |
Economic satisfaction, n (%) | ||
Good | 23 (39.7) | 23 (37.7) |
Sufficient | 22 (37.9) | 31 (50.8) |
Poor/bad | 13 (22.4) | 7 (11.5) |
Total number comorbidities, median (IQR) | 2.0 (1.0–4.0) | 2.0 (1.0–3.0) |
Total number medications, median (IQR) | 2.0 (1.0–4.0) | 2.0 (1.0–3.0) |
Confirmed arthritis, n (%) | 19 (32.8) | 18 (29.5) |
Confirmed cardiovascular disease, n (%) | 9 (15.5) | 14 (23.0) |
CES-D score (0–60), median (IQR) | 8.0 (3.0–14.0) | 6.5 (3.25–11.0) |
Moderate risk of functional decline, n (%) | 7 (11.9) | 6 (10) |
LLFDI score (0–100), mean (SD) | ||
Functional (overall) | 73.7 (12.9) | 73.1 (10.6) |
Lower extremities basic | 85.3 (15.3) | 83.6 (12.7) |
Lower extremities advanced | 70.5 (15.7) | 71.5 (15.4) |
Upper extremities | 88.0 (12.7) | 87.7 (12.1) |
Disability frequency | 52.2 (4.6) | 50.5 (4.0) |
Disability limitation (0–100), median (IQR) | 84 (72.6–100.0) | 80 (72–100) |
Behavioural complexity score, mean (SD) | 0.347 (0.123) | 0.374 (0.119) |
aLiFE, adapted Lifestyle-integrated Functional Exercise; CES-D, Center for Epidemiological Studies Depression; eLiFE, enhanced Lifestyle-integrated Functional Exercise; LLFDI, Late-Life Function and Disability Index.